Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K | 10-K |
Revenues: |
United States | 472.8 | 338.2 | 199.0 | 105.4 |
Rest of world | 100.7 | 63.5 | 28.1 | 8.7 |
Canada | 80.1 | 56.9 | 29.9 | 12.5 |
Total revenues | 653.6 | 458.6 | 257.0 | 126.6 |
Revenue growth [+] | 42.5% | 78.5% | 103.0% | |
United States | 39.8% | 69.9% | 88.9% | |
Rest of world | 58.5% | 126.2% | 222.3% | |
Canada | 40.8% | 90.5% | 138.9% | |
Cost of goods sold | 326.9 | 237.1 | 135.8 | 73.3 |
Gross profit | 326.6 | 221.5 | 121.1 | 53.3 |
Gross margin | 50.0% | 48.3% | 47.1% | 42.1% |
Selling, general and administrative [+] | 302.2 | 191.8 | 105.5 | 69.2 |
Sales and marketing | 171.0 | 120.9 | 73.8 | 43.5 |
General and administrative | 131.3 | 70.9 | 31.7 | 25.7 |
Research and development | 138.7 | 64.1 | 40.8 | 32.0 |
EBITDA [+] | -114.3 | -34.5 | -25.1 | -47.9 |
EBITDA growth | 231.7% | 37.2% | -47.6% | |
EBITDA margin | -17.5% | -7.5% | -9.8% | -37.9% |
Depreciation and amortization | 6.7 | 5.3 | 4.1 | 2.7 |
EBIT [+] | -121.0 | -39.7 | -29.2 | -50.6 |
EBIT growth | 204.7% | 36.1% | -42.3% | |
EBIT margin | -18.5% | -8.7% | -11.4% | -40.0% |
Interest income, net [+] | 2.8 | -1.1 | -0.9 | -0.5 |
Interest expense | 1.3 | 1.3 | 1.2 | 1.6 |
Interest income | 4.1 | 0.1 | 0.3 | 1.1 |
Other income (expense), net | 5.2 | 3.1 | -1.3 | 0.0 |
Pre-tax income | -113.0 | -37.7 | -31.4 | -51.1 |
Income taxes | 1.0 | 1.0 | 1.2 | 0.3 |
Net income | -114.0 | -38.8 | -32.6 | -63.5 |
Net margin | -17.4% | -8.5% | -12.7% | -50.2% |
|
Basic EPS [+] | ($0.68) | ($0.64) | ($1.52) | ($2.98) |
Growth | 6.5% | -57.9% | -49.1% | |
Diluted EPS [+] | ($0.68) | ($0.64) | ($1.52) | ($2.98) |
Growth | 6.5% | -57.9% | -49.1% | |
|
Shares outstanding (basic) [+] | 167.8 | 60.7 | 21.5 | 21.3 |
Growth | 176.3% | 183.0% | 0.8% | |
Shares outstanding (diluted) [+] | 167.8 | 60.7 | 21.5 | 21.3 |
Growth | 176.3% | 183.0% | 0.8% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|